These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16885801)

  • 1. [Management of ocular hypertension and chronic open-angle glaucoma by French ophthalmologists: the role of target intraocular pressure].
    Laplace O; Bron A; Nordmann JP
    J Fr Ophtalmol; 2006 Apr; 29(4):353-8. PubMed ID: 16885801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
    Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
    J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of glaucoma patients with insufficient intraocular pressure control: a survey of German ophthalmologists in private practice.
    Vorwerk C; Thelen U; Buchholz P; Kimmich F
    Curr Med Res Opin; 2008 May; 24(5):1295-301. PubMed ID: 18366862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the 1-day postoperative IOP check needed post uncomplicated phacoemulsification in patients with glaucoma and ocular hypertension?
    Gupta A; Vernon SA
    Eye (Lond); 2015 Oct; 29(10):1299-307. PubMed ID: 25697456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of dorzolamide–timolol (COSOPT) in patients who were treatment naive for open-angle glaucoma or ocular hypertension: the COSOPT first-line study.
    Crichton AC; Harasymowycz P; Hutnik CM; Behki R; Boucher S; Ibrahim F; Rifkind AW; Solomon L; Liao C; Bastien NR; Sampalis JS
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):503-11. PubMed ID: 20874498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of first- or second-line latanoprost on intraocular pressure and ocular symptoms in patients with open-angle glaucoma or ocular hypertension].
    Baudouin C; Rouland JF; Nordmann JP; Bron A; Pelen F
    J Fr Ophtalmol; 2006 Jun; 29(6):615-24. PubMed ID: 16885890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study.
    Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Suganami H; Araie M;
    Acta Ophthalmol; 2015 Jun; 93(4):e254-60. PubMed ID: 25487877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.
    Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
    Adv Ther; 2015 Sep; 32(9):823-37. PubMed ID: 26424331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: strategies, clinical outcomes, and costs at 1 year.
    Rouland JF; Le Pen C;
    Eur J Ophthalmol; 2003 Jul; 13 Suppl 4():S5-20. PubMed ID: 12948049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silicone punctal plugs as an adjunctive therapy for open-angle glaucoma and ocular hypertension.
    Opitz DL; Tung S; Jang US; Park JJ
    Clin Exp Optom; 2011 Sep; 94(5):438-42. PubMed ID: 21342261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension.
    Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Fukushima A; Suganami H; Araie M;
    Acta Ophthalmol; 2016 Feb; 94(1):e26-34. PubMed ID: 26338317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
    Lopes JF; Hubatsch DA; Amaris P
    BMC Ophthalmol; 2015 Nov; 15():166. PubMed ID: 26563363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.
    DuBiner HB; Mroz M; Shapiro AM; Dirks MS;
    Clin Ther; 2001 Dec; 23(12):1969-83. PubMed ID: 11813932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between intraocular pressure level and optic disc changes in high-tension glaucoma suspects.
    Tanito M; Itai N; Dong J; Ohira A; Chihara E
    Ophthalmology; 2003 May; 110(5):915-21. PubMed ID: 12750089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension.
    Ling Z; Zhang M; Hu Y; Yin Z; Xing Y; Fang A; Ye J; Chen X; Liu D; Wang Y; Sun W; Dong Y; Sun X
    Chin Med J (Engl); 2014; 127(5):905-10. PubMed ID: 24571886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.
    Kuwayama Y; Hashimoto M; Kakegawa R; Nomura A; Shimada F
    Adv Ther; 2017 Jun; 34(6):1411-1425. PubMed ID: 28502035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
    Weinreb RN; Scassellati Sforzolini B; Vittitow J; Liebmann J
    Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European glaucoma prevention study design and baseline description of the participants.
    Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
    Ophthalmology; 2002 Sep; 109(9):1612-21. PubMed ID: 12208707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence With the Use of Target Intraocular Pressure for Glaucoma Patients in a Large University Practice.
    Solano-Moncada F; Dymerska M; Jefferys JL; Quigley HA
    J Glaucoma; 2016 Apr; 25(4):e424-32. PubMed ID: 26550977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
    Simmons ST; Earl ML;
    Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.